More Potential
International Women's Day
“Without gender equality, a sustainable future remains beyond our reach.”
Search
40 Result(s)
Driving Innovation through Diversity & Inclusion
International Women’s Day: breaking barriers, building gender and health equity
On International Women’s Day, we join forces to collectively strive for gender and health equity, empowering women in and beyond our company.
More Potential
Women at the workplace: Inspiring inclusion for positive change
Leadership views on how to enhance women’s progress at work
Heart Failure
Heart Failure in Women
Gain knowledge on how gender disparities appear in heart failure care. You’ll hear from global experts on how women can be supported through their journey and empowered to manage their care, from diagnosis to disease management.
More Potential
Passion for science
Discover how our women excelling in STEM careers can improve health equity and create sustainable healthcare solutions.
Our Stories
Be curious, go change the world
Female scientists at Boehringer Ingelheim drive innovation and make medicine happen.
More Health: For People & Animals
At the heart of health equity
Introducing initiatives that improve access to healthcare for underserved communities
More Green
The impact of carbon reduction projects
With climate contributions we not only help conservating wildlife and forests but also support female rangers in Kenya and communities in Guatemala
More Health: For People & Animals
Helping smallholder farmers overcome hardship caused by Covid-19
Happy Farmer Campaign in collaboration with Cowtribe supports farmers in Ghana.
Diabetes
Empagliflozin in real-world clinical care
Learn about the EMPRISE real-world evidence study and use of empagliflozin in routine clinical care
June 06, 2022
Jardiance® (empagliflozin) decreased relative risk of hospitalization for heart failure by 50% versus DPP-4 inhibitors and by 30% versus GLP-1 receptor agonists in adults with type 2 diabetes in real-world evidence study
Our Stories
Boosting Performance with an Inclusive Performance Culture
Listen to audio recordings of a panel discussion on inclusive performance culture
November 17, 2019
Interim analysis from EMPRISE real-world study shows empagliflozin decreased risk of hospitalisation for heart failure compared with DPP-4 inhibitors and GLP-1 receptor agonists
Pulmonary Fibrosis
Facts about IPF
IPF is a debilitating and fatal lung disease.
February 24, 2022
FDA Grants BI 1015550 Breakthrough Therapy Designation for Idiopathic Pulmonary Fibrosis
About Us
On the road with sanitation workers in India
Exhaust fumes, heat, work and traffic accidents. Overcoming all these odds, the sanitation workers in India fight a daily battle. Making More Health is committed to help.
May 15, 2022
Investigational treatment slowed lung function decline in IPF
Article
Ethical Business Practices
Suppliers shall conduct their business in an ethical manner and act with integrity.
August 27, 2021
Landmark trial demonstrates empagliflozin is the first therapy to show statistically significant improvement in heart failure outcomes in adults with preserved ejection fraction
History
History (1990-2023): Value through Innovation
Join us on the way towards the new millennium and learn more about the latest discoveries and developments since then.
Human Health Products
Viramune®
Scleroderma
The little things
In 2009 Anna was diagnosed with scleroderma. For her, however, the disease is no reason to give up. On the contrary.
Skin Diseases
A guide to hidradenitis suppurativa (HS)
A long-term, inflammatory, recurrent skin condition causing painful inflamed nodules or abscesses on the skin.
Scleroderma
Scleroderma Life Hacks
Video series featuring people living with scleroderma using everyday items in different ways to help them manage their symptoms.
August 27, 2020